Migraine with Isolated Facial Pain: Diagnosis and Management

Diagnostic Criteria

Migraine attacks must last 4–72 hours and can present with isolated facial pain in the V2/V3 trigeminal zones; diagnosis is supported when at least two of the following are present—unilateral location, throbbing/pulsatile quality, moderate‑to‑severe intensity, and worsening with routine physical activity—plus at least one associated symptom (nausea/vomiting or photophobia/phonophobia)【1】.

Trigeminal neuralgia is characterized by brief, electric‑shock‑like pain triggered by light touch, typically episodic, and responds best to carbamazepine【2】.
Cluster headache requires ≥5 attacks of unilateral orbital, supra‑orbital, or temporal pain lasting 15–180 minutes with ipsilateral autonomic features (lacrimation, nasal congestion, ptosis, miosis, eyelid edema); its absence makes this diagnosis unlikely in isolated facial pain【1】.

The U.S. Headache Consortium advises no routine neuroimaging for patients with typical migraine features and no neurologic abnormalities【1】.
MRI of the brain and trigeminal nerve is indicated when any of the following are identified: atypical headache pattern, focal neurologic signs, progressive pain, sensory disturbances, or the need to exclude tumors, multiple sclerosis, or neurovascular compression【1】.

History should capture exact episode duration (4–72 h), frequency, pain quality (throbbing vs. stabbing), common migraine triggers (hormonal changes, certain foods, sensory stimuli, missed meals, stress), aggravating factors (routine activity, chewing, facial touch), and associated symptoms (nausea, vomiting, photophobia, phonophobia, visual changes, nasal symptoms, tearing)【2】【1】.
Physical exam includes a full neurologic assessment, evaluation of facial sensation across all three trigeminal divisions, and searching for trigger points typical of trigeminal neuralgia【2】.

Acute therapy: a trial of triptans is recommended as first‑line treatment for migraine with isolated facial pain; a positive response can also serve as a diagnostic confirmation【1】.
Preventive therapy for chronic migraine (≥15 days/month for ≥3 months, with migraine features on ≥8 days/month) is limited to onabotulinumtoxinA, the only FDA‑approved preventive agent for this indication【1】.
If the triptan trial fails, carbamazepine should be initiated to address possible trigeminal neuralgia, with referral for neurosurgical evaluation if pain remains uncontrolled【2】.

The American Academy of Neurology suggests that 68-95% of patients self-diagnosed with "sinus headache" actually have migraine or tension-type headache, not sinusitis 3

The British Journal of Anaesthesia recommends analyzing the temporal pattern of pain to distinguish between primary headache disorders and true structural/neuropathic facial pain syndromes 4, 5
The International Headache Society suggests that migraine attacks lasting 4-72 hours, occurring on ≥8 days/month if chronic, are a key diagnostic feature 6
The American Academy of Neurology recommends suspecting migraine if the patient has unilateral location with throbbing character, moderate-to-severe intensity worsening with routine activity, associated nausea/vomiting OR photophobia and phonophobia, and duration of 4+ hours per episode 3, 6

The American College of Rheumatology recommends immediately checking ESR and C-reactive protein to exclude giant cell arteritis—a vision-threatening emergency—in patients over 50 years with new-onset unilateral facial/temporal pain 3, 5, 7

The American Academy of Neurology suggests that acute treatment for migraine features should include a trial of triptans for acute episodes, and preventive treatment for chronic migraine (≥15 days/month) should include topiramate or amitriptyline 3, 8
The British Journal of Anaesthesia recommends carbamazepine as first-line treatment for trigeminal neuralgia, and neurosurgery for refractory cases 4, 7

The American Academy of Neurology advises against diagnosing sinusitis based on facial pain alone without purulent nasal discharge, and against prescribing antibiotics for symptoms <10 days unless severe or worsening 3
The American College of Surgeons recommends against performing sinus surgery for isolated facial pain without documented inflammation and failed medical therapy 3

The American Academy of Neurology suggests referring patients to a specialized neurologist for neuropathies, headache, and facial pain if diagnosis remains unclear 9, 10, 5